Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.

Pharmaceutical

Oncopeptides

Sofia Heigis ️

Eva Nordström

Anders Martin-Löf

Jakob Lindberg

Sara Svärdgren

Henrik Bergentoft

Lisa Swedel

Stefan Norin

Karolina Vilval

Lisa Andersson

Per Wold-Olsen

Jonas Brambeck

Brian Stuglik

Per Samuelsson

Jennifer Jackson

Cecilia Daun Wennborg

The Corporate Governance team at Oncopeptides AB is responsible for ensuring compliance with regulatory requirements and best practices in corporate governance. This team, comprising key executives and board members, focuses on strategic decision-making, risk management, and fostering transparent communication with stakeholders, all while supporting the company's mission to advance innovative anti-cancer treatments.

Corporate Governance

The Medical Affairs and Clinical Operations team at Oncopeptides AB is responsible for overseeing the design and execution of clinical trials, ensuring the scientific integrity of research, and facilitating communication between clinical data and regulatory bodies. This team collaborates with medical professionals to provide crucial insights into anti-cancer products, supports regulatory submissions, and ensures the efficient supply of investigational drugs for clinical studies, all aimed at advancing patient care in oncology.

Medical Affairs and Clinical Operations

The Research and Development team at Oncopeptides AB is dedicated to advancing anti-cancer therapies through innovative research and rigorous clinical testing. Comprising experts in various scientific disciplines, the team collaborates to develop, optimize, and translate novel compounds into effective treatments, ensuring that their findings translate into real-world benefits for patients battling cancer.

Research and Development

The Leadership Team at Oncopeptides AB is responsible for guiding the strategic direction of the organization, overseeing clinical development initiatives, and ensuring the successful delivery of innovative anti-cancer treatments. They collaborate across functions to align business goals with scientific advancements, manage financial performance, and promote effective communication both internally and externally, all while prioritizing patient outcomes.

Leadership Team

The Clinical and Regulatory Affairs team at Oncopeptides AB is responsible for overseeing the development and compliance of clinical trials for anti-cancer therapies. This team ensures that all processes meet regulatory standards, monitors the safety of treatments through pharmacovigilance, and facilitates communication with regulatory bodies to secure approvals for new therapies. Their expertise plays a critical role in advancing innovative treatments from research to clinical application for the benefit of patients.

Clinical and Regulatory Affairs

The Financial and Investor Relations team at Oncopeptides AB is responsible for managing the company's financial strategies and communication with investors. They ensure accurate financial reporting, oversee accounting practices, and cultivate relationships with stakeholders to effectively convey the company's progress and potential in anti-cancer research. Through transparent financial disclosures, the team aims to build investor confidence and support for the company's clinical advancements.

��

Oncopeptides

Org chart

Board & advisors

Teams

Corporate Governance

Medical Affairs and Clinical Operations

Research and Development

Leadership Team

Clinical and Regulatory Affairs

Financial and Investor Relations

Offices

��������

Oncopeptides

Org chart

Board & advisors

Teams

Corporate Governance

Medical Affairs and Clinical Operations

Research and Development

Leadership Team

Clinical and Regulatory Affairs

Financial and Investor Relations

Offices

Related companies

��